CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for DermTech Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

DermTech Inc
12340 EL CAMINO REAL
Phone: (858) 450-4222p:858 450-4222 SAN DIEGO, CA  92130  United States Ticker: DMTKDMTK

Business Summary
DermTech, Inc. is a molecular diagnostic company. The Company is engaged in developing and marketing non-invasive genomics tests to aid in the diagnosis and management of melanoma. Its technology enhances evaluation of lesions suspicious for melanoma using non-invasive sample collection and detecting genomic markers associated with melanoma to identify higher risk lesions or rule out melanoma with a 99% or higher negative predictive value (NPV). It offers DermTech Melanoma Test (the DMT), which is a non-invasive way to enhance evaluation of pigmented lesions suspicious for melanoma. Its genomics platform has been designed to work with its Smart Sticker, which provides an easy and non-invasive way to collect a skin sample, in contrast to the existing standard of care of using a scalpel to biopsy suspicious lesions. It also provides its research services and technology platform on a contract basis to pharmaceutical companies that use the technology to support their clinical trials.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202312/31/2023YesYes---

Industries
SIC Code Description
8734 Testing laboratories
2834 Pharmaceutical preparations
6770 Blank checks

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Board Matthew L.Posard 56 8/1/2019 8/1/2019
President, Chief Executive Officer, Director BretChristensen 52 5/8/2023 5/8/2023
Chief Financial Officer, Treasurer, Secretary Kevin M.Sun 45 1/1/2022 9/1/2019
6 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
DermTech Operations, Inc. 11099 N Torrey Pines Rd Ste 100 LA JOLLA CA United States

Business Names
Business Name
@Derma, Inc.
CNAC
CNACU
4 additional Business Names available in full report.

General Information
Number of Employees: 206 (As of 12/31/2023)
Outstanding Shares: 69,148,120 (As of 2/23/2024)
Shareholders: 163
Stock Exchange: NASD
Federal Tax Id: 842870849
Fax Number: (858) 200-3877


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024